M. T. Corasaniti, G. W. Lawrence, G. Bagetta, R. Iannacchero, A. Tarsitano, A. Monteleone, . . . D. Scuteri. (2023). Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: A retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety. Frontiers Media S.A..
Chicago Style (17th ed.) CitationM. T. Corasaniti, et al. Combination of Anti-CGRP/CGRP-R MAbs with Onabotulinumtoxin A as a Novel Therapeutic Approach for Refractory Chronic Migraine: A Retrospective Study of Real-world Clinical Evidence and a Protocol for a Double-blind, Randomized Clinical Trial to Establish the Efficacy and Safety. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationM. T. Corasaniti, et al. Combination of Anti-CGRP/CGRP-R MAbs with Onabotulinumtoxin A as a Novel Therapeutic Approach for Refractory Chronic Migraine: A Retrospective Study of Real-world Clinical Evidence and a Protocol for a Double-blind, Randomized Clinical Trial to Establish the Efficacy and Safety. Frontiers Media S.A., 2023.